MAPT and Alzheimer disease: As the disease progresses, some DLB patients have AD pathological manifestations, with deposition of Aβ and tau proteins, while DLB patients with AD pathology progress more rapidly, and most patients develop moderate to severe disease, especially in the medial temporal lobe (23, 57, 64).